title: Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension.
authors.forename: Michael
authors.initials: M
authors.lastname: Halank
authors.forename: Stephan
authors.initials: S
authors.lastname: Miehlke
authors.forename: Gert
authors.initials: G
authors.lastname: Hoeffken
authors.forename: Alexander
authors.initials: A
authors.lastname: Schmeisser
authors.forename: Matthias
authors.initials: M
authors.lastname: Schulze
authors.forename: Ruth H
authors.initials: RH
authors.lastname: Strasser
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000188:drug therapy*; D006976:Hypertension, Pulmonary / Q000150:complications / Q000188:drug therapy*; D008297:Male; D013449:Sulfonamides / Q000008:administration & dosage*
chemical_list: D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan